Tea Rosic

512 total citations
43 papers, 315 citations indexed

About

Tea Rosic is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Clinical Psychology. According to data from OpenAlex, Tea Rosic has authored 43 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 19 papers in Epidemiology and 16 papers in Clinical Psychology. Recurrent topics in Tea Rosic's work include Opioid Use Disorder Treatment (19 papers), Substance Abuse Treatment and Outcomes (17 papers) and Prenatal Substance Exposure Effects (9 papers). Tea Rosic is often cited by papers focused on Opioid Use Disorder Treatment (19 papers), Substance Abuse Treatment and Outcomes (17 papers) and Prenatal Substance Exposure Effects (9 papers). Tea Rosic collaborates with scholars based in Canada, United States and South Africa. Tea Rosic's co-authors include Zainab Samaan, Lehana Thabane, David C. Marsh, Nitika Sanger, Leen Naji, Brittany B. Dennis, Andrew Worster, Monica Bawor, Carolyn Plater and Stephanie Sanger and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Drug and Alcohol Dependence.

In The Last Decade

Tea Rosic

37 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tea Rosic Canada 11 146 141 91 75 62 43 315
Laura Zielinski Canada 9 145 1.0× 143 1.0× 65 0.7× 40 0.5× 68 1.1× 16 308
Miren Iza United States 6 156 1.1× 128 0.9× 64 0.7× 40 0.5× 57 0.9× 9 314
Petros Levounis United States 11 125 0.9× 163 1.2× 97 1.1× 45 0.6× 27 0.4× 22 394
Crystal Lederhos Smith United States 9 97 0.7× 172 1.2× 79 0.9× 109 1.5× 84 1.4× 38 378
Ivar Skeie Norway 8 171 1.2× 142 1.0× 72 0.8× 51 0.7× 22 0.4× 21 331
Katherine Lovinger United States 9 175 1.2× 133 0.9× 97 1.1× 72 1.0× 38 0.6× 12 390
Caroline Yoo United States 9 135 0.9× 169 1.2× 37 0.4× 60 0.8× 36 0.6× 19 262
Patricia Dumont Switzerland 8 104 0.7× 150 1.1× 73 0.8× 62 0.8× 31 0.5× 10 325
Jessica A. Dreifuss United States 7 283 1.9× 289 2.0× 70 0.8× 107 1.4× 48 0.8× 9 451

Countries citing papers authored by Tea Rosic

Since Specialization
Citations

This map shows the geographic impact of Tea Rosic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tea Rosic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tea Rosic more than expected).

Fields of papers citing papers by Tea Rosic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tea Rosic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tea Rosic. The network helps show where Tea Rosic may publish in the future.

Co-authorship network of co-authors of Tea Rosic

This figure shows the co-authorship network connecting the top 25 collaborators of Tea Rosic. A scholar is included among the top collaborators of Tea Rosic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tea Rosic. Tea Rosic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodrigues, Myanca, Jordan Edwards, Tea Rosic, et al.. (2025). A tutorial on the what, why, and how of Bayesian analysis: Estimating mood and anxiety disorder prevalence using a Canadian data linkage study. PLOS mental health.. 2(2). e0000253–e0000253.
2.
Bach, Paxton, M. Eugenia Socías, Nadia Fairbairn, et al.. (2025). Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020. Drug and Alcohol Dependence. 273. 112703–112703. 2 indexed citations
3.
4.
Rosic, Tea, Myanca Rodrigues, Brittany B. Dennis, et al.. (2025). Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care. PLoS ONE. 20(1). e0314296–e0314296. 1 indexed citations
5.
Naji, Leen, Tea Rosic, Brittany B. Dennis, et al.. (2025). Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data. BMJ Open. 15(6). e095645–e095645.
6.
Kelleher, Kelly J., William Gardner, Alex R. Kemper, et al.. (2024). Principles for Primary Care Screening in the Context of Population Health. Academic Pediatrics. 24(5). 719–727. 2 indexed citations
7.
Rosic, Tea, et al.. (2023). Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021. JAMA Network Open. 6(7). e2321947–e2321947. 8 indexed citations
8.
Eddeen, Anan Bader, Peter Tanuseputro, Claire Kendall, et al.. (2023). Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol. Academic Emergency Medicine. 31(3). 220–229. 2 indexed citations
9.
Sanger, Nitika, et al.. (2022). The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review. Patient Related Outcome Measures. Volume 13. 113–130. 8 indexed citations
10.
Naji, Leen, Tea Rosic, Nitika Sanger, et al.. (2022). Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data. Frontiers in Psychiatry. 13. 1046649–1046649. 3 indexed citations
11.
Rosic, Tea, Leen Naji, Nitika Sanger, et al.. (2021). Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment. Journal of Addiction Medicine. 16(4). e257–e264. 9 indexed citations
12.
13.
Rosic, Tea, Leen Naji, Nitika Sanger, et al.. (2021). The association between cannabis use and outcome in pharmacological treatment for opioid use disorder. Harm Reduction Journal. 18(1). 24–24. 14 indexed citations
14.
Rosic, Tea, Nitika Sanger, Myanca Rodrigues, et al.. (2021). Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review. Journal of Medical Case Reports. 15(1). 586–586. 5 indexed citations
15.
Rosic, Tea, et al.. (2021). Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls. Neuropsychiatric Disease and Treatment. Volume 17. 545–554. 3 indexed citations
16.
Rosic, Tea, Nitika Sanger, Andrew Worster, et al.. (2021). Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?. Harm Reduction Journal. 18(1). 71–71. 11 indexed citations
17.
Rosic, Tea, Nitika Sanger, Gary Foster, et al.. (2021). Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada. Substance Abuse Treatment Prevention and Policy. 16(1). 34–34. 4 indexed citations
18.
Rosic, Tea, et al.. (2020). Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy. Schizophrenia Bulletin Open. 1(1). sgaa007–sgaa007. 10 indexed citations
19.
Naji, Leen, Tea Rosic, Nitika Sanger, et al.. (2020). The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder. Journal of Addiction Medicine. 15(5). 370–375. 2 indexed citations
20.
Rosic, Tea, Leen Naji, Monica Bawor, et al.. (2017). The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatric Disease and Treatment. Volume 13. 1399–1408. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Zielinski Breakdown of academic impact, for papers by Miren Iza Breakdown of academic impact, for papers by Petros Levounis Breakdown of academic impact, for papers by Crystal Lederhos Smith Breakdown of academic impact, for papers by Ivar Skeie Breakdown of academic impact, for papers by Katherine Lovinger Breakdown of academic impact, for papers by Caroline Yoo Breakdown of academic impact, for papers by Patricia Dumont Breakdown of academic impact, for papers by Jessica A. Dreifuss
Rankless by CCL
2026